Pinnacle is seeking expressions of interest from general practice to deliver COVID-19 vaccination as part of the vaccine rollout for Groups 3 and 4 from June/July onwards (priority populations and the remainder of the general population). General practice would be part of the wider rollout - one of many options for patients.
New Zealand has purchased the Pfizer/BioNTech vaccine for the full population. The vaccine has very specific cold chain requirements which currently restrict its use. It is likely these restrictions will be reduced and it is possible another vaccine may become available. This information is changing frequently.
Cold chain requirements update 1 June: Medsafe has received data from Pfizer to vary the storage conditions for their COVID-19 vaccine. This data has been assessed and Medsafe has approved the new conditions for use in New Zealand. This change means that the refrigerated (2°C to 8°C) shelf life of an unopened vial of Comirnaty vaccine is extended from 5 days to 31 days.
For these reasons, we are approaching practices with two different requests for consideration.
Responding to this EOI does not commit your practice to delivering COVID-19 vaccine. It is purely letting Pinnacle know your practice is interested and further correspondence will occur once more details are known.
NZ is currently rolling out the COVID-19 vaccination programme through DHBs, mainly via hubs, however a range of vaccination delivery channels will be needed as the programme progresses through the population.
Pinnacle want to explore an opt-in COVID-19 vaccination model that pulls on the expertise of primary care where there is interest and availability. This would sit alongside the central mass vaccination model and outreach service.
There is not an expectation that general practice can absorb all the vaccination work, but we believe there is potential general practice could work alongside other vaccination models planned for our communities.
There is opportunity for practices to design what the service looks like for their business and populations, including options such as delivering vaccination as part of an afterhours service or working with other practices in the region to develop a hub-type model.
A standard fee for service price of $36.05 (excl GST) for each vaccination, which will increase to $48.72 (excl GST) for vaccinations that are provided out of hours.
Update 1 June: Medsafe has received data from Pfizer to vary the storage conditions for their COVID-19 vaccine. This data has been assessed and Medsafe has approved the new conditions for use in New Zealand.
This change means that the refrigerated (2°C to 8°C) shelf life of an unopened vial of Comirnaty vaccine is extended from 5 days to 31 days. Once at 2°C to 8°C, the vial cannot be returned to the freezer and must be disposed of after 31 days or on the vial’s expiration date (whichever happens first). The vaccine still needs to be kept at ultra-low temperatures (-90°C to -60°C) in the longer term, for up to six months.
Further information about the approved storage conditions for the Pfizer vaccine can be found in the New Zealand data sheet.
To vaccinate Group 3 and 4, practices will need to have the following organised.
There are a variety of ways in which this could work for practices, including teaming up with other practices in your community and holding a weekend vaccination clinic, opening your practice weekends/after hours for a vaccination clinic or working within a business-as-usual model and vaccinating alongside this.
Please make sure your response to this EOI is a practice-wide decision completed by close of business Tuesday 27 April.
Responding to this EOI does not commit your practice to COVID-19 vaccination delivery. It is purely letting Pinnacle know your practice is interested and further correspondence will occur with your practice directly once more details are known.
Jan Adams, Nursing Director
021 904 460
Jo Scott-Jones, Medical Director
027 475 0488
Michelle Bayley, Clinical Governance Programme Manager
027 590 1241